Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-06-19
1981-12-22
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3119
Patent
active
043071147
ABSTRACT:
Disclosed are new methods of using (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3- acetic acid or a therapeutically acceptable salt thereof with an organic or inorganic base for the treatment of complications associated with diabetes mellitus. The compound inhibits lens aldose reductase in a diabetic mammal.
REFERENCES:
patent: 3647858 (1972-03-01), Hinkley
patent: 3654349 (1972-04-01), Shen et al.
patent: 3821383 (1974-06-01), Sestanj
PDR, 34 Edition, 1980, pp. 1147-1149.
Clin. Pharmacol. Ther, 21, 231 (1977), Ryan et al.
Dvornik Dushan M.
Simard-Duquesne Nicole
Ayerst McKenna & Harrison, Inc.
Mandel Adley F.
Waddell Frederick E.
LandOfFree
Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(meth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(meth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2367837